53377-61-0 Usage
Uses
Used in Pharmaceutical Industry:
1,3,5-Trihydroxy-4-prenylxanthone is used as a potential therapeutic agent for its antimicrobial, antimutagenic, anti-inflammatory, and antiviral properties. Its diverse pharmacological benefits make it a promising candidate for the development of new drugs to treat various diseases.
Used in Anticancer Applications:
1,3,5-Trihydroxy-4-prenylxanthone is used as an anticancer agent due to its potential anti-cancer activities. Further research is needed to establish its safe and effective therapeutic dosing and to explore its synergistic effects when combined with conventional chemotherapeutic drugs.
Used in Drug Delivery Systems:
To enhance the applications and efficacy of 1,3,5-Trihydroxy-4-prenylxanthone, novel drug delivery systems are being developed. These systems aim to improve the delivery, bioavailability, and therapeutic outcomes of 1,3,5-Trihydroxy-4-prenylxanthone, particularly in the context of cancer treatment. Various organic and metallic nanoparticles are being explored as carriers for 1,3,5-Trihydroxy-4-prenylxanthone delivery.
Check Digit Verification of cas no
The CAS Registry Mumber 53377-61-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,3,7 and 7 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 53377-61:
(7*5)+(6*3)+(5*3)+(4*7)+(3*7)+(2*6)+(1*1)=130
130 % 10 = 0
So 53377-61-0 is a valid CAS Registry Number.
53377-61-0Relevant academic research and scientific papers
Helesbeux, Jean-Jacques,Duval, Olivier,Dartiguelongue, Caroline,Séraphin, Denis,Oger, Jean-Michel,Richomme, Pascal
, p. 2293 - 2300 (2004)
Application of our original photooxidation-reduction methodology to prenylated dihydroxycoumarin and trihydroxyxanthone compounds led to the corresponding ortho-(2-hydroxy-3-methylbut-3-enyl)phenol derivatives with yields ranging from 8 to 65%. In most of the reported experiments, the oxidation products distribution, after the photooxygenation step, was controlled by the competition between the large group effect and the stabilising phenolic assistance effect. We also showed that ortho-(3-hydroxy-3- methylbut-1-enyl)phenol derivatives could be considered as biogenetic precursors of 2,2-dimethylbenzopyranic structures.
